[Clinical utility of serum tumor markers in lung cancer]

Zhongguo Fei Ai Za Zhi. 2011 Mar;14(3):286-91. doi: 10.3779/j.issn.1009-3419.2011.03.16.
[Article in Chinese]

Abstract

Lung cancer shows a tendency of higher incidence and higher mortality in recent years, but the overall 5-year survival rate is less than 15%. Serum tumor markers of lung cancer play an important role in early diagnosis, determining of pathology types, staging, evaluation of response, and prognosis of lung cancer. In this review, 6 most important markers were reviewed, including neuron-specific enolase (NSE), pro-gastrin-releasing peptide (ProGRP), cytokeratin 19 fragments (Cyfra 21-1), tissue polypeptide antigen (TPA), squamous cell carcinoma associated antigen (SCC-Ag), carcinoembryonic antigen (CEA).

肺癌血清肿瘤标志物在肺癌的早期诊断、病理分型、疾病分期、疗效评估和指导预后等方面起着重要的作用,本文旨在对神经元特异性烯醇化酶(NSE)、胃泌素释放肽(ProGRP)、细胞角蛋白19片段(CYFRA 21-1)、组织多肽抗原(TPA)、鳞状细胞癌相关抗原(SCC-Ag)和癌胚抗原(CEA)这6种重要的肺癌血清肿瘤标志物的临床意义进行综述。

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biomarkers, Tumor / blood*
  • Humans
  • Lung Neoplasms / blood*
  • Lung Neoplasms / diagnosis
  • Lung Neoplasms / pathology

Substances

  • Biomarkers, Tumor